Biotech euphoria driven by fundamentals

Jonathan Faison, who runs ROTY Biotech Community (seekingalpha.com/checkout/mp_1243?source=ie_po…), says recent biotech euphoria driven by fundamentals and M&A appetite (0:50) 3 $10B+ buyouts with Nuvalent, Apogee, and Crinetics (2:15) Sector ETFs and metrics to focus on (7:00) Bullish on Journey Medical (seekingalpha.com/symbol/DERM?source=ie_podcast…) (14:40)

Show Notes:
Vertex to acquire Crinetics Pharmaceuticals in $10B deal (seekingalpha.com/news/4611780-vertex-to-acquir…)
Making Money In Biotech Stocks (seekingalpha.com/article/4828961-making-money-…)

Episode transcripts (seekingalpha.com/author/investing-experts-podc…)

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions?source=ie_podca…